ScinoPharm Taiwan, Ltd. (1789.TW)
TWD 18.75
(3.88%)
TWD 18.75
(3.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 231.12 Million | 773.79 Million | 509.82 Million | 946.31 Million | 788.94 Million | 1.23 Billion |
| Net Income | 348.84 Million | 437.96 Million | 302.28 Million | 358.5 Million | 265.05 Million | 490.54 Million |
| Depreciation & Amortization | 461.16 Million | 439.46 Million | 381.53 Million | 393.19 Million | 408.71 Million | 405.82 Million |
| Deferred income taxes | - | - | - | 11.4 Million | -162.13 Million | -167.63 Million |
| Stock-based compensation | - | - | - | 84 Thousand | 2.05 Million | 5.68 Million |
| Change in working capital | -489.07 Million | -24.36 Million | -94.43 Million | 254.34 Million | 276.26 Million | 453.91 Million |
| Other non-cash items | -89.8 Million | -79.27 Million | -79.55 Million | -71.22 Million | -1 Million | 43.27 Million |
| Investing Cash Flow | -233.29 Million | -253.61 Million | -69.98 Million | 241.72 Million | -98.38 Million | -299.99 Million |
| Investments in PPE | -284.71 Million | -250.04 Million | -321.32 Million | -183.09 Million | -105.7 Million | -127.04 Million |
| Acquisitions | 136 Thousand | 291 Thousand | -6.66 Million | -2.99 Million | -2.99 Million | 4.07 Million |
| Investment purchases | -136 Thousand | -47.98 Million | -348.91 Million | 136.94 Million | -710.89 Million | -1.21 Billion |
| Sales/Maturities of investments | 51.13 Million | 44.14 Million | 595.76 Million | 283.5 Million | 722.12 Million | 1.03 Billion |
| Other Investing Activities | 293 Thousand | -32 Thousand | 11.14 Million | 7.35 Million | -931 Thousand | -1.7 Million |
| Financing Cash Flow | -340.97 Million | -314.82 Million | -412.77 Million | -444.9 Million | -1.57 Billion | -627.03 Million |
| Debt repayment | -107.46 Million | -77.28 Million | -9.49 Million | -312.11 Million | -1.35 Billion | -411.21 Million |
| Dividends payments | -284.66 Million | -379.55 Million | -395.37 Million | -213.5 Million | -387.46 Million | -379.55 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 51.15 Million | 142.01 Million | -7.91 Million | 80.7 Million | 172.75 Million | 163.73 Million |
| Accounts receivables | -154.86 Million | -259.6 Million | 69.97 Million | 195.78 Million | 2.19 Million | 100.48 Million |
| Accounts payables | -23.98 Million | 55.57 Million | -89.98 Million | 58.65 Million | 11.62 Million | -1.39 Million |
| Inventory | -347.47 Million | 157.63 Million | -81.36 Million | -47.95 Million | 293.84 Million | 340.14 Million |
| Other working capital | 37.24 Million | 22.04 Million | 6.92 Million | 47.87 Million | -31.4 Million | 113.77 Million |
| Cash at beginning of period | 4.29 Billion | 4.08 Billion | 4.05 Billion | 3.3 Billion | 4.2 Billion | 3.91 Billion |
| Cash at end of period | 3.94 Billion | 4.29 Billion | 4.08 Billion | 4.05 Billion | 3.3 Billion | 4.2 Billion |
| Capital Expenditure | -284.71 Million | -250.04 Million | -321.32 Million | -183.09 Million | -105.7 Million | -127.04 Million |
| Effect of forex changes on cash | -10.04 Million | 8.44 Million | -1.09 Million | 6.84 Million | -17.05 Million | -12.01 Million |
| Net cash flow / Change in cash | -353.18 Million | 213.78 Million | 25.97 Million | 749.97 Million | -898.36 Million | 292.54 Million |
| Free Cash Flow | -53.58 Million | 523.74 Million | 188.5 Million | 763.21 Million | 683.24 Million | 1.1 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 74.88 Million | 175.05 Million | 190.95 Million | 348.84 Million | 39.06 Million | 66.11 Million |
| Depreciation & Amortization | 121.46 Million | 119.42 Million | 117.22 Million | 461.16 Million | 113.47 Million | 114.56 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -118.17 Million | 60.53 Million | -287.46 Million | -489.07 Million | -4.15 Million | -221.05 Million |
| Other non-cash items | 339.26 Million | 6.06 Million | 37.76 Million | -89.8 Million | -23.9 Million | -108.31 Million |
| Investing Cash Flow | -43.88 Million | -91.69 Million | -76.02 Million | -233.29 Million | -68.66 Million | -22.39 Million |
| Investments in PPE | -43.86 Million | -91.74 Million | -76.03 Million | -284.71 Million | -68.74 Million | -73.58 Million |
| Acquisitions | - | - | - | 136 Thousand | 136 Thousand | - |
| Investment purchases | - | - | - | -136 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | 51.13 Million | - | 51.07 Million |
| Other Investing Activities | -19 Thousand | 51 Thousand | 6000.00 | 293 Thousand | -56 Thousand | 118 Thousand |
| Financing Cash Flow | -13.35 Million | -15.85 Million | -27.71 Million | -340.97 Million | -311.37 Million | -11.82 Million |
| Debt repayment | -10.22 Million | -12.31 Million | -25.38 Million | -107.46 Million | -24.33 Million | -5.9 Million |
| Dividends payments | - | - | - | -284.66 Million | -284.66 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -5000.00 | -437 Thousand | -2.33 Million | 51.15 Million | -2.37 Million | -5.91 Million |
| Accounts receivables | 63.84 Million | 253.31 Million | -426.45 Million | -154.86 Million | 196.82 Million | -149.43 Million |
| Accounts payables | -50.11 Million | 96.15 Million | -39.51 Million | -23.98 Million | -32.77 Million | 6.67 Million |
| Inventory | -152.86 Million | -175.33 Million | 80.43 Million | -347.47 Million | -131.96 Million | -74.19 Million |
| Other working capital | 20.95 Million | -112.91 Million | 98.06 Million | 37.24 Million | -36.24 Million | -4.1 Million |
| Cash at beginning of period | 4.22 Billion | 3.94 Billion | 3.99 Billion | 4.29 Billion | 4.24 Billion | 4.43 Billion |
| Cash at end of period | 4.2 Billion | 4.22 Billion | 3.94 Billion | 3.94 Billion | 3.99 Billion | 4.24 Billion |
| Capital Expenditure | -43.86 Million | -91.74 Million | -76.03 Million | -284.71 Million | -68.74 Million | -73.58 Million |
| Effect of forex changes on cash | 2.83 Million | 7.44 Million | -7.82 Million | -10.04 Million | 8.38 Million | -9.03 Million |
| Net cash flow / Change in cash | -19.02 Million | 284.3 Million | -53.09 Million | -353.18 Million | -247.16 Million | -191.94 Million |
| Free Cash Flow | -8.49 Million | 292.66 Million | -17.56 Million | -53.58 Million | 55.74 Million | -222.27 Million |
6855
KALO
FCONSUMER
7374
5310
1907